Normal-Tension Glaucoma
Understanding glaucomatous injury and vulnerability beyond elevated intraocular pressure.
Advancing glaucoma research through objective measures of retinal ganglion cell function, early identification of neuronal vulnerability, and investigation of modifiable risk factors.
Explore our research →Founded in 2019, Glaucoma Research Organization (GRO), LLC is an independent, physician-scientist-led research organization focused on glaucoma and related ophthalmic research.
Our current work centers on investigator-initiated studies in normal-tension glaucoma, early retinal ganglion cell dysfunction, and potentially modifiable risk factors beyond intraocular pressure.
Our mission and vision →Understanding glaucomatous injury and vulnerability beyond elevated intraocular pressure.
Investigating pattern electroretinography as an objective measure of retinal ganglion cell function.
Examining obstructive sleep apnea and other systemic contributors to glaucomatous injury.
Exploring whether early neuronal stress offers opportunities for functional recovery and earlier intervention.
Preliminary investigator-initiated research has observed improvements in electrophysiological measures of retinal ganglion cell function following treatment for obstructive sleep apnea.
These observations warrant further longitudinal investigation.
Founder & Medical Director
Professor of Ophthalmology and physician-scientist with more than 25 years of experience in ophthalmic clinical research, development, and medical affairs.
Meet GRO’s leadership →We welcome scientific inquiries and discussions of potential research collaboration.
Contact GRO →